Diabetes care company Animas is to close down. This means that in the long term, Animas Vibe insulin pumps will no longer be available.
The sale of all Animas Vibe and OneTouch Ping insulin pumps has been discontinued with immediate effect in the US and Canada.
For Europe and the UK this process, which will see Animas ceasing operation and sale of pumps, will take much longer.
Johnson & Johnson, the firm behind Animas, said on 5 October 2017 that Animas pumps and products will continue to be available through healthcare providers and for sale as normal in the UK for an as yet unconfirmed but limited period of time.
Johnson & Johnson will provide further information for UK Animas pump users, including what their options are for using different pumps, in due course.
The firm has also said Animas will continue to provide customer service, training and warranty support, including providing pump supplies that are used with the Animas Vibe, during a limited ‘transition period’. The length of time this will be available has yet to be confirmed.
Other Johnson & Johnson Diabetes Care companies, including blood glucose monitoring focused Lifescan, which includes OneTouch branded products, and Calibra, producers of an insulin patch pump, are not included in this change.
Karen Addington, UK Chief Executive of JDRF said:
“This news is concerning and JDRF is monitoring the situation. Users of these particular insulin pumps must not be negatively affected in any way. They should be supported by Animas and their healthcare team to move smoothly on to alternative pumps.”
If you have any questions about how this might affect you please call Animas Patient Support on 0800 055 6606 in the UK or 1800 812 715 in Republic of Ireland.